Open-Label, Flexible-dose Study to Evaluate the Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia or Bipolar I Disorder

Conditions:   Schizophrenia;   Bipolar I Disorder Intervention:   Drug: Cariprazine Flexible Dose Sponsor:   Allergan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials